Targeting RBM39 Disrupts Mitosis and Sensitizes Triple-Negative Breast Cancer Cells
In triple-negative breast cancer cell lines and organoids, pharmacologic targeting of the splicing factor RBM39 disrupts mitotic fidelity and increases ...
In triple-negative breast cancer cell lines and organoids, pharmacologic targeting of the splicing factor RBM39 disrupts mitotic fidelity and increases ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.